PCYN (Procyon) Beginning Cash Position: $0.33 Mil (As of Jun. 2024)


PCYN Procyon Corp PCYN
48 GF Score
Price $0.20
View Full Analysis

What is Procyon Beginning Cash Position?

Procyon PCYN 48 Beginning Cash Position is $0.33 Mil as of Jun. 2024. GuruFocus rates PCYN with a GF Score™ of 48/100.

Procyon's Beginning Cash Position for the quarter that ended in Jun. 2024 was $0.33 Mil.

Procyon's quarterly Beginning Cash Position declined from Dec. 2023 ($0.40 Mil) to Mar. 2024 ($0.27 Mil) but then increased from Mar. 2024 ($0.27 Mil) to Jun. 2024 ($0.33 Mil).

Procyon's annual Beginning Cash Position declined from Jun. 2022 ($1.23 Mil) to Jun. 2023 ($0.76 Mil) and declined from Jun. 2023 ($0.76 Mil) to Jun. 2024 ($0.45 Mil).

Procyon Beginning Cash Position Related Terms

Procyon Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Procyon's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procyon Beginning Cash Position Chart

Procyon Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.67 1.23 0.76 0.45

Procyon Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.45 0.40 0.27 0.33
PCYN
48GF Score
Procyon Corp PCYN
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procyon Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.33 Mil mean?
Procyon (PCYN) has a Beginning Cash Position of $0.33 Mil as of Jun. 2024. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Procyon and its competitors.
Is Procyon's Beginning Cash Position too high?
Procyon's current Beginning Cash Position is $0.33 Mil. Overall, Procyon has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Procyon's Beginning Cash Position compare to KAYS and YCBD?
Procyon's Beginning Cash Position of $0.33 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Procyon and its competitors. Procyon's current Beginning Cash Position is $0.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procyon stock overvalued right now?
Procyon (PCYN) has a current Beginning Cash Position of $0.33 Mil. The current Beginning Cash Position is $0.33 Mil. Procyon's overall GF Score™ is 48/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Procyon (PCYN), the current Beginning Cash Position is $0.33 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Procyon Business Description

Address 164 Douglas Road East, Oldsmar, FL, USA, 34677
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
48GF Score

Get the complete analysis for PCYN

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price